CyPB Antibodies

Santa Cruz Biotechnology delivers a wide array of CyPB monoclonal antibodies for investigating Cyclophilin B (CyPB) in various biological processes. CyPB Antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclophilin B plays an essential role in protein folding and trafficking, while also regulating immune responses. Research has shown that Cyclophilin B significantly influences cellular processes such as apoptosis and signal transduction. Understanding Cyclophilin B function is crucial for investigating disease mechanisms and developing therapeutic interventions. Cyclophilin B research continues to reveal important insights about its involvement in cancer and autoimmune diseases. Current studies focus on how Cyclophilin B influences cellular pathways and molecular interactions. Ongoing research explores the potential of Cyclophilin B as a therapeutic target in various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies for Cyclophilin B support researchers worldwide in advancing scientific knowledge and developing new therapeutic strategies.